JIVI [antihemophilic factor (recombinant), PEGylated-aucl] lyophilized powder for solution, for intravenous use

Bayer

Jivi, antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age and older) with hemophilia A (congenital Factor VIII deficiency) for:

• On-demand treatment and control of bleeding episodes
• Perioperative management of bleeding
• Routine prophylaxis to reduce the frequency of bleeding episodes

24 months

Store Jivi at 2°C to 8°C (36°F to 46°F) for up to 24 months from the date of manufacturer. Do not freeze. Within this period, Jivi may be stored for a single period of up to 6 months at temperatures up to 25°C or 77°F.

Record the starting date of room temperature storage on the unopened product carton. Once stored at room temperature, do not return the product to the refrigerator. The shelf-life then expires after storage at room temperature for 6 months, or after the expiration date on the product vial, whichever is earlier.

Do not use Jivi after the expiration date indicated on the vial.

Protect Jivi from extreme exposure to light and store the vial with the lyophilized powder in the carton prior to use.